Escolar Documentos
Profissional Documentos
Cultura Documentos
September 2006
USER MANUAL
SOP NUMBER EDITION NUMBER DATE OF ISSUE REVIEW INTERVAL AUTHOR (SIGNATURE) SMRSARL_UM_2006 2.0 September 2006 Annually Dr. Donald Morrison
AUTHORISED BY (SIGNATURE)
August 2006
JM Hutchinson
September 2006
September 2006
Laboratory Hours Normal Laboratory Hours Monday - Friday 8.00 am - 5.00 pm Out of hours Under exceptional circumstances tests will be performed outside the normal laboratory hours.
September 2006
Services Available Tests performed on all isolates received Phenotypic confirmation of MRSA status is carried out on all isolates received. Isolates are phenotypically typed using biotype and antibiogram. Genotyping is currently by PCR-ribotyping (MSSA) and PFGE (MRSA). Phenotypic characteristics of Scottish MRSA are still being monitored. Confirmation of MRSA status Isolates giving equivocal results with the standard tests for species identification of Staphylococcus aureus are tested by PCR to detect the species specific nuc gene. Isolates with borderline resistance to methicillin are tested by oxacillin and cefoxitin E-tests and by PCR to detect the mecA gene. Antibiotic susceptibility monitoring Isolates are tested for resistance to 22 antibiotics (using VITEK and several others by disc diffusion). The resulting antibiogram is part of the phenotyping pattern; it is also used to monitor changing resistance patterns. Isolates with reduced susceptibility to mupirocin are further tested by PCR for the presence of the mupA gene to distinguish between high and low level mupirocin resistance. VISA (Vancomycin intermediate resistant Staphylococcus aureus) screen All referred isolates are screened, using a Break Point plate assay, for reduced susceptibility to vancomycin. Isolates positive on screening are further tested by E-test and broth microdilution MIC assay. Epidemiological typing By phenotypic typing (using biotype and antibiogram), more than 90% of MRSA isolates are assigned to known epidemic strains. Genotyping by PCR-ribotyping (PCR-R) and pulsed field gel electrophoresis (PFGE) is carried out on MSSA and MRSA respectively. PFGE type of MSSA and CNS is also performed if appropriate. PFGE is the more discriminatory technique and is particularly valuable in the investigation of localised outbreaks. PCR-R is a rapid method and although, less descrimatory, is useful for identifying clonal groups and can also be used for speciation of CNS. Sequenced based typing (MLST and spa typing) is carried out on selected isolates and will be used more widely in future.
September 2006
Toxin Testing PCR tests are routinely available for detection of 9 staphylococcal toxin genes: five enterotoxin genes (sea, seb, sec, sed and see), the toxic shock sydrome toxin-1 (tst), two exofoliative toxins (eta and etb) and the Panton-Valentine Leukocidin gene. Other toxin genes are under evaluation. Snapshot Programme Because hospitals referral policies differ, a "Snapshot" programme has been initiated, in collaboration with HPS, to obtain a more comprehensive picture of MRSA epidemiology in Scotland. In a rolling program, and by mutual agreement, each hospital is allocated a two week period when all "new" MRSA isolates are sent to the MRSA reference laboratory with epidemiological information. Control of infection advice Advice on the various aspects of the control of MRSA infection is available. Staphylococci other than MRSA Many of the tests performed in the Reference Laboratory are useful in the investigation of other Staphylococci. Epidemiological typing of MSSA and CNS by PFGE and species identification of CNS by phenotypic and genotypic (PCR based) methods will be undertaken on request.
September 2006
Referral Policy Samples referred will be accepted from laboratories throughout Scotland. Advice and information will be provided to clinicians and agencies Scotland-wide. As a minimum, every laboratory should send specimens to the Reference Laboratory where confirmation that an isolate is an MRSA is necessary. At the discretion of the sending laboratory, the following should be sent to the Reference Laboratory: All outbreak/cross-infection isolates (MRSA, MSSA and CNS) All blood cultures (MRSA and MSSA) as part of the EARSS surveillance programme Isolates with unusual characteristics or those whose characteristics have changed CNS requiring identification to the species level
All new MRSA isolates identified within a mutually agreed period (between 1 and 4 weeks) each year should also be submitted (Snapshot programme). The Reference Laboratory will be expected to work closely with SCIEH to obtain maximum value from this national surveilliance and to report back the results of this pilot to the commissioner in the Annual Report.
September 2006
How to Obtain Services Specimens pure cultures on agar slopes (preferably in bijoux bottles) or on swabs in transport medium. Request forms Fill out the details on the request forms as completely as possible (request forms are available from SMRSARL directly or from the website, forms can be photocopied). Postal address Specimens should be sent to: Scottish MRSA Reference Laboratory Department of Microbiology Stobhill Hospital Balornock Road Glasgow G21 3UW Urgent specimens A "fast track" system is available for urgent specimens. Please telephone to request "fast tracking" of specimen and to notify when the specimen will arrive
September 2006
Notes 1. Includes phenotypic confirmation of MRSA status and genotypic typing. 2. Time from receipt of pure culture until report has been posted. Working days do not include weekends. Time refers to 95% of referrals. 3. Urgent specimens will be "fast tracked". From receipt of pure culture PCR confirmation of MRSA status can be performed in 1 day and PFGE typing in 3 days.
September 2006
Teaching, Research & Development The reference laboratory is committed to the teaching of medical and technical staff and has a continuing commitment to Research & Development activities relevant to the work of the laboratory. This includes collaborative work with microbiologists, Infection Control Nurses, scientists and biomedical scientists in referring hospitals.
Community MRSA MRSA in animals Antiseptic testing Molecular characterisation of MRSA clones Staphylococcus aureus with intermediate susceptibility to vancomycin (VISA) Evaluation of media for MRSA screening
September 2006
Problems, Complaints and Service Improvements If any problems are encountered with the service or any matter for complaint arises, please contact the Director, Prof. Curtis Gemmell (0141-211-4654). In addition, suggestions for improvement of the service are welcomed
September 2006
Postal address Scottish MRSA Reference Laboratory Department of Microbiology Stobhill Hospital Balornock Road Glasgow G21 3UW